Safety and Efficacy Study of JV-GL1 in Patients With Open-Angle Glaucoma or Ocular Hypertension

Clinical trial NCT04761705 · SUSPENDED

Trial details

NCT number: NCT04761705
Sponsor: JeniVision, Inc.
Status: SUSPENDED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Ocular Hypertension Open Angle Glaucoma

Start date: 2021-03-10
Primary completion: 2025-03-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.